Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Taiwan Bio Therapeutics Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05724576
- Locations
- 🇨🇳
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung city, Taiwan
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Phase 2
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Taiwan Bio Therapeutics Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT05027581
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Beitou District, Taiwan
🇨🇳Taipei Municipal Wangfang Hospital (Managed by Taipei Medical University), Taipei, Wenshan District, Taiwan
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Taiwan Bio Therapeutics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02336646
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
News
No news found